EUVIMEDEUVIMED entdecken
Crossref

The FAK‐NRF2 Axis Alleviates DOX‐Induced Cardiotoxicity by Inhibiting Ferroptosis

Ying Zhao, Mo Chen, Linghui Kong, Shufei Wu, Cheng Teng, Song Hu, Kangjie Xie, Jiankui Du, Xiaoyan Zhu iD, Pengxiang Wang, Pingbo Xu iD

The FASEB Journal · 2025

DOI: 10.1096/fj.202501368r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Ying Zhao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Ferroptosis, Doxorubicin, Cardiotoxicity. Die Arbeit nennt 68 Literaturangaben. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), Chinese Academy of Sciences, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Doxorubicin (DOX), a prevalent anthracycline chemotherapeutic agent, is associated with considerable cardiotoxicity, the molecular mechanisms of which remain incompletely understood. Focal adhesion kinase (FAK), a non‐receptor protein tyrosine kinase, plays a crucial role in cardiac survival signaling during both developmental and pathological stress conditions. In this study, we demonstrate that FAK overexpression in SKOV3 mice and AC16 cardiomyocytes ameliorates DOX‐induced cardiomyopathy by inhibiting ferroptosis. Mechanistically, DOX treatment induces ferroptosis in cardiomyocytes by suppressing FAK activity. Furthermore, we reveal that FAK overexpression reduces DOX cardiotoxicity, at least in part, through the upregulation of the transcription factor Nuclear factor erythroid 2‐related factor 2 (NRF2). The protective effects of FAK against myocardial injury are nullified by NRF2 knockdown. Additionally, histone deacetylase 5 (HDAC5) may be involved in this protective pathway. These findings identify FAK as a critical regulator of DOX‐induced cardiotoxicity and suggest that enhancing the FAK/NRF2/HDAC5 signaling axis in cardiac tissue could represent a promising strategy for preserving myocardial function in patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-E2-Related Factor 2FerroptosisDoxorubicinCardiotoxicityFocal Adhesion Kinase 1Focal Adhesion Protein-Tyrosine KinasesAnimalsMiceMyocytes, CardiacHumansSignal TransductionHistone DeacetylasesMice, Inbred C57BL

Stichwörter der Autor:innen

DOXFAKHDAC5NRF2cardiotoxicity

Substanzen

NF-E2-Related Factor 2DoxorubicinFocal Adhesion Kinase 1Nfe2l2 protein, mouseHistone DeacetylasesFocal Adhesion Protein-Tyrosine KinasesPtk2 protein, mouseHdac5 protein, mouse

Autor:innen und Institutionen

  • Department of Anesthesiology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China.
  • Laboratory of Anesthesia and Perioperative Medicine, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China.
  • Department of Physiology, Naval Medical University, Shanghai, China.

ORCID-Profile: Xiaoyan Zhu, Pingbo Xu

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)
  • Chinese Academy of Sciences
  • National Natural Science Foundation of China

Zitieren

APA

Zhao, Y., Chen, M., Kong, L., Wu, S., Teng, C., Hu, S., Xie, K., Du, J., Zhu, X., Wang, P., & Xu, P. (2025). The FAK‐NRF2 Axis Alleviates DOX‐Induced Cardiotoxicity by Inhibiting Ferroptosis. The FASEB Journal. https://doi.org/10.1096/fj.202501368r

Vancouver

Zhao Y, Chen M, Kong L, Wu S, Teng C, Hu S, et al. The FAK‐NRF2 Axis Alleviates DOX‐Induced Cardiotoxicity by Inhibiting Ferroptosis. The FASEB Journal. 2025. doi:10.1096/fj.202501368r

BibTeX
@article{Zhao2025,
  author = {Zhao, Ying and Chen, Mo and Kong, Linghui and Wu, Shufei and Teng, Cheng and Hu, Song and Xie, Kangjie and Du, Jiankui and Zhu, Xiaoyan and Wang, Pengxiang and Xu, Pingbo},
  title = {The FAK‐NRF2 Axis Alleviates DOX‐Induced Cardiotoxicity by Inhibiting Ferroptosis},
  journal = {The FASEB Journal},
  year = {2025},
  doi = {10.1096/fj.202501368r}
}
Kostenlos starten →